A Pilot Clinical Trial of Cetuximab Combined With Tislelizumab as Neoadjuvant Therapy for Locally Advanced Oral Squamous Cell Carcinoma.

Wu WJ, An PG, Hu X, Zhang JY, Chen Y, Yao J, Zhang J

Open source

DOI
10.1002/hed.70463
Published
2026 Sep 6
Container
Head & neck
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/hed.70463,
  title = {A Pilot Clinical Trial of Cetuximab Combined With Tislelizumab as Neoadjuvant Therapy for Locally Advanced Oral Squamous Cell Carcinoma.},
  author = {Wu WJ and An PG and Hu X and Zhang JY and Chen Y and Yao J and Zhang J},
  year = {2026},
  journal = {Head \& neck},
  doi = {10.1002/hed.70463},
  url = {https://doi.org/10.1002/hed.70463}
}

RIS

TY  - JOUR
TI  - A Pilot Clinical Trial of Cetuximab Combined With Tislelizumab as Neoadjuvant Therapy for Locally Advanced Oral Squamous Cell Carcinoma.
AU  - Wu WJ
AU  - An PG
AU  - Hu X
AU  - Zhang JY
AU  - Chen Y
AU  - Yao J
AU  - Zhang J
PY  - 2026
JO  - Head & neck
DO  - 10.1002/hed.70463
UR  - https://doi.org/10.1002/hed.70463
ER  - 

APA

WJ, W., PG, A., X, H., JY, Z., Y, C., J, Y., & J, Z. (2026). A Pilot Clinical Trial of Cetuximab Combined With Tislelizumab as Neoadjuvant Therapy for Locally Advanced Oral Squamous Cell Carcinoma.. Head & neck. https://doi.org/10.1002/hed.70463

Source records